Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (171-180 of 251) with videos related to

Pageof 26
Sort By:
The Yale Journal of Biology and Medicine|September 1, 1992
The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotideL K Kvols, J C Reubi, U Horisberger, et al.
American Journal of Clinical Oncology|June 1, 1983
A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinomaJ Rubin, S Sorensen, A J Schutt, et al.
JAMA|August 25, 1993
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
Cancer Treatment Reports|May 1, 1983
Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancerA J Schutt, R G Hahn, C G Moertel, et al.
The New England Journal of Medicine|January 17, 1985
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparisonC G Moertel, T R Fleming, E T Creagan, et al.
American Journal of Clinical Oncology|August 1, 1983
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinomaJ Rubin, L K Kvols, C G Moertel, et al.
Cancer Treatment Reports|September 1, 1981
Phase II trial of iv 6-thioguanine in advanced colorectal carcinomaJ C Britell, C G Moertel, L K Kvols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1984
Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinomaM J O'Connell, C G Moertel, J Rubin, et al.
Mayo Clinic Proceedings|August 1, 1985
Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liverM J O'Connell, M A Adson, A J Schutt, et al.
The New England Journal of Medicine|September 11, 1986
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogueL K Kvols, C G Moertel, M J O'Connell, et al.
Pageof 26

Showing results (171-180 of 251) with videos related to

Sort By:
Pageof 26
The Yale Journal of Biology and Medicine|September 1, 1992
The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotideL K Kvols, J C Reubi, U Horisberger, et al.
American Journal of Clinical Oncology|June 1, 1983
A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinomaJ Rubin, S Sorensen, A J Schutt, et al.
JAMA|August 25, 1993
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
Cancer Treatment Reports|May 1, 1983
Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancerA J Schutt, R G Hahn, C G Moertel, et al.
The New England Journal of Medicine|January 17, 1985
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparisonC G Moertel, T R Fleming, E T Creagan, et al.
American Journal of Clinical Oncology|August 1, 1983
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinomaJ Rubin, L K Kvols, C G Moertel, et al.
Cancer Treatment Reports|September 1, 1981
Phase II trial of iv 6-thioguanine in advanced colorectal carcinomaJ C Britell, C G Moertel, L K Kvols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1984
Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinomaM J O'Connell, C G Moertel, J Rubin, et al.
Mayo Clinic Proceedings|August 1, 1985
Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liverM J O'Connell, M A Adson, A J Schutt, et al.
The New England Journal of Medicine|September 11, 1986
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogueL K Kvols, C G Moertel, M J O'Connell, et al.
Pageof 26